STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
LPCN LIPOCINE INCORPORATED StockScouter® Report
8
StockScouter® Score
LIPOCINE INCORPORATED, a micro cap company in the healthcare sector, is expected to outperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The enterprise value-to-sales ratio is much lower than the average for comparably-sized companies in the StockScouter universe. Very Positive
- The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
- Moving average analysis for LPCN suggests strong price movement over the medium term. Positive
Concerns
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
C
C
A
B